Lifeline Scientific (LSE:LSI) Interest Expense : £-0.03 Mil (TTM As of Jun. 2016)

View and export this data going back to . Start your Free Trial

What is Lifeline Scientific Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Lifeline Scientific's interest expense for the six months ended in Jun. 2016 was £ -0.00 Mil. Its interest expense for the trailing twelve months (TTM) ended in Jun. 2016 was £-0.03 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Lifeline Scientific's Operating Income for the six months ended in Jun. 2016 was £ 1.42 Mil. Lifeline Scientific's Interest Expense for the six months ended in Jun. 2016 was £ -0.00 Mil. Lifeline Scientific's Interest Coverage for the quarter that ended in Jun. 2016 was 711.50. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lifeline Scientific Interest Expense Historical Data

The historical data trend for Lifeline Scientific's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lifeline Scientific Interest Expense Chart

Lifeline Scientific Annual Data

Trend

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dec14

Dec15

Interest Expense

Get a 7-Day Free Trial

-0.06

-0.05

-0.06

-0.07

-0.05

Lifeline Scientific Semi-Annual Data
	Jun09	Dec09	Jun10	Dec10	Jun11	Dec11	Jun12	Dec12	Jun13	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16
Interest Expense	Get a 7-Day Free Trial										-0.03	-0.03	-0.02	-0.03	-

Lifeline Scientific Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Jun. 2016 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.03 Mil.

Lifeline Scientific (LSE:LSI) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Lifeline Scientific's Interest Expense for the six months ended in Jun. 2016 was £-0.00 Mil. Its Operating Income for the six months ended in Jun. 2016 was £1.42 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Jun. 2016 was £0.02 Mil.

Lifeline Scientific's Interest Coverage for the quarter that ended in Jun. 2016 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Jun. 2016 )	/	Interest Expense (Q: Jun. 2016 )
	=	-1	*	1.423	/	-0.002
	=	711.50

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies interest coverage is at least 5. Lifeline Scientific Inc has enough cash to cover all of its debt. Its financial situation is stable.

Lifeline Scientific (LSE:LSI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lifeline Scientific Inc (LSE:LSI) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.lifeline-scientific.com

Lifeline Scientific Inc was incorporated on October 1, 1998. The Company is in the business of delivering, to targeted medical markets, a portfolio of related proprietary technologies, which include devices, solutions, and protocols designed to maximize the use and availability of organs, tissues, and cells. It serves the kidney transplant market today with its LifePort product line, and also sells solutions to service the broader organ transplant industry. The Company operates in North America, Brazil, China and Rest of World.